Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Dolby Laboratories (NYSE:DLB - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 12,591 shares of the electronics maker's stock, valued at approximately $1,011,000.
Several other large investors have also recently bought and sold shares of the company. Orion Portfolio Solutions LLC boosted its holdings in Dolby Laboratories by 0.7% in the 4th quarter. Orion Portfolio Solutions LLC now owns 19,522 shares of the electronics maker's stock valued at $1,525,000 after purchasing an additional 132 shares during the period. Securian Asset Management Inc. boosted its holdings in Dolby Laboratories by 3.0% in the 1st quarter. Securian Asset Management Inc. now owns 4,648 shares of the electronics maker's stock valued at $373,000 after purchasing an additional 137 shares during the period. Synovus Financial Corp boosted its holdings in Dolby Laboratories by 0.5% in the 4th quarter. Synovus Financial Corp now owns 32,235 shares of the electronics maker's stock valued at $2,518,000 after purchasing an additional 173 shares during the period. Net Worth Advisory Group boosted its holdings in Dolby Laboratories by 5.2% in the 1st quarter. Net Worth Advisory Group now owns 3,591 shares of the electronics maker's stock valued at $288,000 after purchasing an additional 178 shares during the period. Finally, CANADA LIFE ASSURANCE Co boosted its holdings in Dolby Laboratories by 0.5% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 44,954 shares of the electronics maker's stock valued at $3,511,000 after purchasing an additional 216 shares during the period. 58.56% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
DLB has been the subject of a number of research analyst reports. Barrington Research reaffirmed an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a report on Friday, May 2nd. Tigress Financial initiated coverage on shares of Dolby Laboratories in a report on Thursday, May 15th. They set a "buy" rating and a $112.00 price objective for the company. Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Friday, May 30th. Finally, Rosenblatt Securities reaffirmed a "buy" rating and set a $95.00 price objective on shares of Dolby Laboratories in a report on Friday.
Read Our Latest Stock Analysis on DLB
Dolby Laboratories Stock Performance
NYSE DLB opened at $70.19 on Friday. Dolby Laboratories has a 52-week low of $66.35 and a 52-week high of $89.66. The company has a market capitalization of $6.74 billion, a P/E ratio of 25.71 and a beta of 0.91. The company has a fifty day moving average of $74.92 and a 200-day moving average of $77.59.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.06. The business had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.62%. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.71 earnings per share. As a group, analysts forecast that Dolby Laboratories will post 2.94 EPS for the current fiscal year.
Dolby Laboratories Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is 49.81%.
Insider Activity
In other news, SVP John D. Couling sold 675 shares of the company's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $75.04, for a total transaction of $50,652.00. Following the completion of the transaction, the senior vice president directly owned 121,151 shares of the company's stock, valued at approximately $9,091,171.04. This represents a 0.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Mark Andrew Sherman sold 15,000 shares of the business's stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $75.02, for a total transaction of $1,125,300.00. Following the transaction, the executive vice president owned 62,397 shares in the company, valued at $4,681,022.94. This represents a 19.38% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 116,724 shares of company stock valued at $8,764,043. Insiders own 38.39% of the company's stock.
Dolby Laboratories Company Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.